Archives: Resources

Contract Pharma article about how PPD employs flow cytometry in its development of biomarker assays for client studies.

Clinical trial demands are high for the growing expertise in Asian countries.

A brief background of REMS programs; dramatic shifts in the types of REMS approved; challenges associated with multi-sponsor REMS; and how to ensure that your company and products are prepared.

Jürgen Hummel, PPD’s associate statistical science director, was featured in the June issue of PharmaVOICE.

The article discusses the increasing frequency and value of strategic partnerships in driving research advancements.

In the May/June 2013 issue of Drug Discovery & Development, PPD experts discuss how Bayesian modeling can leverage data to aid development of biosimilars.

PPD’s Dirk Reitsma VP and therapeutic head for oncology, was a featured subject matter expert in the April issue of Contract Pharma.

Review PPD’s 1 October 2013 French Sunshine Act document.

Review the French Sunshine Act description of terms document.